Verve Therapeutics(VERV) - 2023 Q2 - Earnings Call Presentation

1 | --- | --- | --- | |-------|---------------------------------------------------------------------------------------------|-------| | | | | | | | | | | | | | | | | | | | | | | Verve Therapeutics | | | | Disrupting the Care of Cardiovascular Disease Through Single-course Gene Editing Medicines | | | | August 2023 | | Forward looking statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and ...